Institute for Clinical Research Malaysia - formerly known as CRC

23/04/2026

𝗟𝗔𝗪𝗔𝗧𝗔𝗡 𝗞𝗘𝗥𝗝𝗔 𝗠𝗘𝗡𝗚𝗘𝗝𝗨𝗧 𝗣𝗘𝗡𝗚𝗔𝗥𝗔𝗛 𝗜𝗖𝗥

23 April 2026 - Pusat Penyelidikan Klinikal (CRC) Hospital Tuanku Jaafar, CRC Hospital Tengku Ampuan Najihah, dan CRC Hospital Melaka hari ini menerima suntikan motivasi melalui Lawatan Kerja Mengejut Pengarah ICR.

Format lawatan ini bertujuan meninjau operasi CRC secara 𝑟𝑒𝑎𝑙 𝑡𝑖𝑚𝑒 di samping memupuk budaya kerja berintegriti dan berprestasi tinggi di kalangan Warga ICR.

Syabas kepada CRC yang terlibat dalam menjiwai nilai perkhidmatan beretika dan berkualiti dalam menyampaikan 𝑅𝑒𝑠𝑒𝑎𝑟𝑐ℎ 𝑡ℎ𝑎𝑡 𝑚𝑎𝑡𝑡𝑒𝑟𝑠 𝑡𝑜 𝑝𝑎𝑡𝑖𝑒𝑛𝑡𝑠

21/04/2026

Setinggi-tinggi tahniah diucapkan kepada YBrs. Dr Murizal Bin Zainol 🎉👏

atas dedikasi dan sumbangan sepanjang berkhidmat sebagai Pengurus NIH, Institut Kesihatan Negara!

Kami dari ICR, merakamkan ucapan sekalung penghargaan dan terima kasih di atas segala penat lelah dan komitmen yang telah diberikan. 💪✨

17/04/2026

17/04/2026

15/04/2026

🔥 Hot off the press! 🔥

“Prevalence of erectile dysfunction among healthy and sexually active Malaysian men aged 18 to 39 years”

📖 Read more below:
https://academic.oup.com/smoa/article/14/3/qfag009/8653755

👏🏻Congratulations to Dato’ Dr. Philip Rajan A/L Devesahayam, Dr. Arvinder Singh from CRC HRPB and team on their outstanding research achievement! 🎉

13/04/2026

Reshared ‼️
📢 𝐉𝐀𝐖𝐀𝐓𝐀𝐍 𝐊𝐎𝐒𝐎𝐍𝐆

📌 Terbuka kepada Pegawai Perubatan KKM berstatus tetap yang berminat dalam penyelidikan
📲 Imbas kod QR untuk permohonan
🗓️ 𝗧𝗔𝗥𝗜𝗞𝗛 𝗧𝗨𝗧𝗨𝗣: 𝟮𝟰 𝗔𝗽𝗿𝗶𝗹 𝟮𝟬𝟮𝟲

👉 Hanya calon yang disenarai pendek akan dihubungi untuk sesi temuduga.

13/04/2026

Congratulations to Dato’ Dr Fam Tem Lom & the study team of Miri Hospital on being the first site in Malaysia to successfully achieve the initial recruitment target for the for Type 2 Diabetes, Hypertension and Cardiovascular Disease Study! Kudos to our study coordinators, Jennifer Tham Ai Ching and Afiatul Effhiza for their contribution. Keep it up team!

13/04/2026

Congratulations to Dr. Voon Pei Jye and the study team at Sarawak General Hospital on randomizing the first patient in Malaysia for the Extensive Stage Small Cell Lung Cancer (ES-SCLC) Study! Kudos to our study coordinators, Philip Anak Mendit, Nurul Husna, Preston Anak Stanley Baling and Wee Wee Buyong for their contribution. Keep it up team!

13/04/2026

Congratulations to Dr Noor Zafifah & the study team of Kuala Lumpur Hospital on randomizing their first patient in Malaysia for the DESTINY Ovarian01 Study! Kudos to our study coordinators, Nur Fadhilah, Puteri Nur Najwa, and Nabilah for their contribution. Keep it up team!

10/04/2026

A proud moment at the NMOSD Conference 2026 🎉

Heartiest congratulations to Shridevi Subramaniam on winning Poster Award (3rd Place) for her outstanding work titled:

“Real-World Safety and Outcomes of Eculizumab in Aquaporin-4 Positive NMOSD: Experience from a Major Tertiary Centre in Malaysia.”

This achievement reflects not only scientific excellence, but also a strong commitment to advancing real-world evidence and improving patient care in NMOSD. Your work is truly inspiring and contributes meaningfully to the growing body of knowledge in this field.

Wishing you continued success in your research journey and many more milestones ahead! 👏✨

10/04/2026

We are delighted to share with you the official launch of the “𝗪𝗛𝗢 𝗚𝗢𝗢𝗗 𝗣𝗥𝗔𝗖𝗧𝗜𝗖𝗘𝗦 𝗙𝗢𝗥 𝗖𝗟𝗜𝗡𝗜𝗖𝗔𝗟 𝗧𝗥𝗜𝗔𝗟 𝗗𝗘𝗦𝗜𝗚𝗡 𝗔𝗡𝗗 𝗜𝗠𝗣𝗟𝗘𝗠𝗘𝗡𝗧𝗔𝗧𝗜𝗢𝗡 𝗖𝗢𝗨𝗥𝗦𝗘 𝗧𝗔𝗞𝗜𝗡𝗚 𝗣𝗟𝗔𝗖𝗘 𝗢𝗡 𝟰 𝗠𝗔𝗬 𝟮𝟬𝟮𝟲 𝗙𝗥𝗢𝗠 𝟭𝟯:𝟬𝟬 – 𝟭𝟰:𝟬𝟬 𝗖𝗘𝗧”.

Register for the launch: https://www.who.int/news-room/events/detail/2026/05/04/default-calendar/strengthening-trust-in-science--launch-of-who-good-practices-for-clinical-trial-design-and-implementation-course

Read and share this post by Dr. Vasee Moorthy (WHO): https://www.linkedin.com/posts/vasee-moorthy-md-phd-21791599_strengthening-trust-in-science-launch-of-activity-7447545239894036481-RTIM

Please share the news of the launch of the free, online, self-paced ‘WHO Good Practices for Clinical Trial Design and Implementation’ course and in 2026. 4 May 2026 13:00 – 14:00 CET Online only. The course is designed for learners with little or no hands-on experience in con...

08/04/2026

🚨 New Publication Alert!

We are pleased to share Dr.Voon Pei Jye’s latest work on the Asia-Pacific practical consensus in the management of adverse events related to Amivantamab-based therapies in Non-Small Cell Lung Cancer (NSCLC).

This consensus brings together regional expertise to provide practical, real-world guidance on identifying and managing treatment-related adverse events—an increasingly important aspect as targeted therapies become more widely adopted in clinical practice.

🤝 This publication reflects a strong collaborative effort among regional experts, reinforcing our shared commitment to translating evidence into actionable clinical practice.
👏 Congratulations to all co-authors and collaborators on this meaningful contribution to thoracic oncology!

Read more here: https://www.lungcancerjournal.info/article/S0169-5002(26)00466-6/abstract